-+ 0.00%
-+ 0.00%
-+ 0.00%

Kingsley Biotechnology (01548): Net trade sales of CARVYKTI® in the second quarter were approximately US$657 million

Zhitongcaijing·07/15/2026 12:33:36
Listen to the news

Zhitong Finance App News, Kingsley Biotech (01548) announced that according to the cooperation and licensing agreement between Legend and Janssen Biotech, Inc. (Janssen) on December 21, 2017, CARVYKTI® generated net trade sales of approximately US$657 million for the quarter ended June 30, 2026.